Moreover, the combination of GFAP with activated protein C–protein C inhibitor complex and the National Institutes of Health Stroke Score led to a diagnostic sensitivity and negative predictive value of 100%, allowing exclusion of haemorrhagic stroke, which is potentially useful for early initiating fibrinolysis. The gene discussed is GFAP; the disease is Stroke.